BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 29572473)

  • 1. Lactobacillus paracasei CNCM I-3689 reduces vancomycin-resistant Enterococcus persistence and promotes Bacteroidetes resilience in the gut following antibiotic challenge.
    Crouzet L; Derrien M; Cherbuy C; Plancade S; Foulon M; Chalin B; van Hylckama Vlieg JET; Grompone G; Rigottier-Gois L; Serror P
    Sci Rep; 2018 Mar; 8(1):5098. PubMed ID: 29572473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fermented milk containing Lactobacillus paracasei subsp. paracasei CNCM I-1518 reduces bacterial translocation in rats treated with carbon tetrachloride.
    Sánchez E; Nieto JC; Vidal S; Santiago A; Martinez X; Sancho FJ; Sancho-Bru P; Mirelis B; Corominola H; Juárez C; Manichanh C; Guarner C; Soriano G
    Sci Rep; 2017 Apr; 7():45712. PubMed ID: 28368023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Microbiota Predict
    Chanderraj R; Brown CA; Hinkle K; Falkowski N; Ranjan P; Dickson RP; Woods RJ
    mSphere; 2020 Nov; 5(6):. PubMed ID: 33208515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct but Spatially Overlapping Intestinal Niches for Vancomycin-Resistant Enterococcus faecium and Carbapenem-Resistant Klebsiella pneumoniae.
    Caballero S; Carter R; Ke X; Sušac B; Leiner IM; Kim GJ; Miller L; Ling L; Manova K; Pamer EG
    PLoS Pathog; 2015 Sep; 11(9):e1005132. PubMed ID: 26334306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential use of probiotic and commensal bacteria as non-antibiotic strategies against vancomycin-resistant enterococci.
    Crouzet L; Rigottier-Gois L; Serror P
    FEMS Microbiol Lett; 2015 Apr; 362(8):fnv012. PubMed ID: 25667231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiota-derived lantibiotic restores resistance against vancomycin-resistant Enterococcus.
    Kim SG; Becattini S; Moody TU; Shliaha PV; Littmann ER; Seok R; Gjonbalaj M; Eaton V; Fontana E; Amoretti L; Wright R; Caballero S; Wang ZX; Jung HJ; Morjaria SM; Leiner IM; Qin W; Ramos RJJF; Cross JR; Narushima S; Honda K; Peled JU; Hendrickson RC; Taur Y; van den Brink MRM; Pamer EG
    Nature; 2019 Aug; 572(7771):665-669. PubMed ID: 31435014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stachyose inhibits vancomycin-resistant Enterococcus colonization and affects gut microbiota in mice.
    Zhu S; Li X; Song L; Huang Y; Xiao Y; Chu Q; Kang Y; Duan S; Wu D; Ren Z
    Microb Pathog; 2021 Oct; 159():105094. PubMed ID: 34280500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrosequencing analysis reveals changes in intestinal microbiota of healthy adults who received a daily dose of immunomodulatory probiotic strains.
    Plaza-Díaz J; Fernández-Caballero JÁ; Chueca N; García F; Gómez-Llorente C; Sáez-Lara MJ; Fontana L; Gil Á
    Nutrients; 2015 May; 7(6):3999-4015. PubMed ID: 26016655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repurposing niclosamide for intestinal decolonization of vancomycin-resistant enterococci.
    Mohammad H; AbdelKhalek A; Abutaleb NS; Seleem MN
    Int J Antimicrob Agents; 2018 Jun; 51(6):897-904. PubMed ID: 29432868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Fidaxomicin versus Vancomycin on Susceptibility to Intestinal Colonization with Vancomycin-Resistant Enterococci and Klebsiella pneumoniae in Mice.
    Deshpande A; Hurless K; Cadnum JL; Chesnel L; Gao L; Chan L; Kundrapu S; Polinkovsky A; Donskey CJ
    Antimicrob Agents Chemother; 2016 Jul; 60(7):3988-93. PubMed ID: 27090175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Surotomycin, a Novel Cyclic Lipopeptide Antibiotic, on Intestinal Colonization with Vancomycin-Resistant Enterococci and Klebsiella pneumoniae in Mice.
    Deshpande A; Hurless K; Cadnum JL; Chesnel L; Gao L; Chan L; Kundrapu S; Polinkovsky A; Donskey CJ
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3333-9. PubMed ID: 26976870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repurposing auranofin as an intestinal decolonizing agent for vancomycin-resistant enterococci.
    AbdelKhalek A; Abutaleb NS; Elmagarmid KA; Seleem MN
    Sci Rep; 2018 May; 8(1):8353. PubMed ID: 29844350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of the esp gene in Enterococcus faecium derived from oropharyngeal microbiota of haematology patients.
    Jovanović M; Tošić T; Jovanović S; Stošović R; Stevanović G; Velebit B; Zervos MJ
    Arch Oral Biol; 2018 Apr; 88():54-59. PubMed ID: 29407752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactobacillus paracasei feeding improves immune control of influenza infection in mice.
    Belkacem N; Serafini N; Wheeler R; Derrien M; Boucinha L; Couesnon A; Cerf-Bensussan N; Gomperts Boneca I; Di Santo JP; Taha MK; Bourdet-Sicard R
    PLoS One; 2017; 12(9):e0184976. PubMed ID: 28931041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic-Driven Dysbiosis Mediates Intraluminal Agglutination and Alternative Segregation of Enterococcus faecium from the Intestinal Epithelium.
    Hendrickx AP; Top J; Bayjanov JR; Kemperman H; Rogers MR; Paganelli FL; Bonten MJ; Willems RJ
    mBio; 2015 Nov; 6(6):e01346-15. PubMed ID: 26556272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbial change after administration of
    Song EJ; Lee ES; Kim YI; Shin DU; Eom JE; Shin HS; Lee SY; Nam YD
    Front Endocrinol (Lausanne); 2023; 14():1224636. PubMed ID: 37705572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiome Resilience despite a Profound Loss of Minority Microbiota following Clindamycin Challenge in Humanized Gnotobiotic Mice.
    Liu L; Kirst ME; Zhao L; Li E; Wang GP
    Microbiol Spectr; 2022 Feb; 10(1):e0196021. PubMed ID: 35019780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new use of
    Buyukeren M; Yigit S; Buyukcam A; Kara A; Celik HT; Yurdakok M
    J Matern Fetal Neonatal Med; 2022 Mar; 35(6):1192-1198. PubMed ID: 32208789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mixture of Lactobacillus species isolated from traditional fermented foods promote recovery from antibiotic-induced intestinal disruption in mice.
    Shi Y; Zhao X; Zhao J; Zhang H; Zhai Q; Narbad A; Chen W
    J Appl Microbiol; 2018 Mar; 124(3):842-854. PubMed ID: 29314490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of clinical enterococci isolates, focusing on the vancomycin-resistant enterococci in a tertiary hospital in China: based on the data from 2013 to 2018.
    Zhou W; Zhou H; Sun Y; Gao S; Zhang Y; Cao X; Zhang Z; Shen H; Zhang C
    BMC Infect Dis; 2020 May; 20(1):356. PubMed ID: 32517758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.